Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Ofer Merimsky
41 années d'expérience
accréditations :
La clinique est certifiée :
| Israël | Turquie | Espagne | |
| Résection de l'estomac | de $22,500 | de $16,470 | de $9,000 |
| Chirurgie du cancer de l'estomac | de $28,500 | de $22,320 | de $25,000 |
| Chimiothérapie pour le cancer du sein | de $22,500 | de $1,200 | de $3,500 |
| Radiothérapie pour le cancer colorectal | - | de $7,000 | de $10,000 |
Le professeur Merimsky dirige l'unité d'oncologie des tissus mous et des os au centre médical Sourasky, fort de décennies d'expérience spécialisée dans le cancer de l'estomac.
Le Dr Pelles Sharon est spécialisée dans la chirurgie du cancer de l'estomac au centre médical Sourasky (Ichilov), avec une expertise dans les traitements avancés tels que le HIPEC et l'immunothérapie.
Il dirige un centre dédié à la prévention du cancer au centre médical Sourasky de Tel Aviv, se concentrant sur le dépistage précoce et le traitement des cancers gastro-intestinaux.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.